Wedge Capital Management L L P NC Has $30.82 Million Stock Holdings in Teleflex Incorporated $TFX

Wedge Capital Management L L P NC lifted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 14.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 252,547 shares of the medical technology company’s stock after purchasing an additional 32,465 shares during the quarter. Wedge Capital Management L L P NC’s holdings in Teleflex were worth $30,821,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. AQR Capital Management LLC increased its stake in Teleflex by 478.1% in the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after acquiring an additional 1,956,811 shares during the period. Abrams Bison Investments LLC acquired a new stake in Teleflex during the third quarter valued at approximately $112,317,000. Norges Bank bought a new stake in shares of Teleflex in the 2nd quarter valued at approximately $65,826,000. Thrivent Financial for Lutherans raised its holdings in shares of Teleflex by 1,161.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 550,449 shares of the medical technology company’s stock worth $67,353,000 after buying an additional 506,796 shares in the last quarter. Finally, Capital International Investors acquired a new position in shares of Teleflex in the 3rd quarter worth approximately $44,851,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex News Summary

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Irenic, a ~2% Teleflex shareholder, called for the Board to form a strategic-review sub‑committee with independent directors and to engage potential acquirers — a direct catalyst for takeover interest that can lift valuation expectations. Irenic Comments on Teleflex’s Announcement That It Is Open to Strategic Alternatives
• Positive Sentiment: Raymond James upgraded Teleflex from Market Perform to Outperform with a $128 price target, signaling analyst conviction that there’s upside from either operational improvement or strategic outcomes. Raymond James upgrade coverage
• Neutral Sentiment: Teleflex issued a formal statement reiterating its commitment to value‑maximizing strategies and said management met with Irenic on March 19 to understand their views — indicates engagement but not yet a formal review process. Teleflex Reiterates Commitment to Value‑Maximizing Strategies and Strong Execution
• Neutral Sentiment: Other shareholders and outlets are echoing calls for Teleflex to engage potential buyers, adding public pressure that could push the Board toward a more formal process. Teleflex shareholder urges company engage buyers
• Negative Sentiment: Teleflex pushed back, saying Irenic falsely claimed the company was not open to buyout offers — the public dispute raises governance/uncertainty risk and could deter some bidders or prolong a process. Teleflex says Irenic falsely claimed company was not open for buyout offers
• Negative Sentiment: Fundamentals remain a headwind: Teleflex reported a large recent earnings and revenue miss and guidance that reflects recovery needs — operational weakness could limit strategic options or depress standalone valuation until results improve.

Teleflex Price Performance

Shares of TFX stock opened at $116.23 on Friday. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $141.91. The company has a current ratio of 2.54, a quick ratio of 2.01 and a debt-to-equity ratio of 0.81. The firm’s 50 day moving average is $109.07 and its 200-day moving average is $116.76. The firm has a market capitalization of $5.14 billion, a price-to-earnings ratio of -5.66, a PEG ratio of 0.69 and a beta of 0.87.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The company had revenue of $569.00 million during the quarter, compared to analyst estimates of $912.57 million. During the same period in the prior year, the business earned $3.89 EPS. The business’s revenue for the quarter was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. Teleflex’s payout ratio is presently -6.62%.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Zacks Research lowered Teleflex from a “hold” rating to a “strong sell” rating in a research note on Monday, March 2nd. Wall Street Zen lowered shares of Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. Truist Financial increased their target price on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research report on Thursday, December 18th. Needham & Company LLC boosted their price objective on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Finally, Wells Fargo & Company increased their target price on Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a report on Friday, February 27th. Three research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $139.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.